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Effects of early exposure to MSG and Phenobarbital
Newspaper and television ads extol the benefits of a multitude of drugs and supplements,
diet products, and flavor enhancers. People take
herbal remedies to fight everything from a cold
to depression, if those don’t work, they obtain a
prescription for one of the many drugs to elevate or alter their mood. Nobody knows yet the
long-term effects of all these substances on the
human body, and in particular on the highly
vulnerable perinate. What may be therapeutic
or safe for the mother, could be toxic to the
fetus and nursing infant. Many of these compounds are too new to have been studied for a
long period of time.
There are two substances that have been
widely available for many years, and they, for
25 years, have been one of the subjects of Dr.
Bernard Shapiro’s funded research. Shapiro,
professor of biochemistry, has studied the
influence of MSG on prenatal and perinatal
development. Fifteen years ago, he added the
drug phenobarbital to his investigations. Why
those two? MSG, commonly known as
monosodium glutamate, is a food additive that
cannot be avoided. It’s in prepared foods, and
has been widely used in the United States since
the 1940s as a flavor enhancer—it is estimated

that Americans consume 200 million lbs. of
MSG or related products annually. Phenobarbital, a barbiturate, is frequently prescribed
to infants in intensive care and to pregnant
women for a variety of commonly occurring
maladies, among them convulsive disorders
that complicate one out of every 200 pregnancies. Prescriptions for pregnant women were
particularly common between the 1950s and
1970s exposing more than 23 million children
in the United States alone. Neither MSG nor
phenobarbital produce visible birth defects,
however, it is thought that they interfere with
the production of a number of liver enzymes,
known as CYPs that are vital to the body’s ability to metabolize drugs and other potentially
toxic substances.
The expression of these drug metabolizing
enzymes is controlled by growth hormone produced by the pituitary. Levels of the hormone
in males and females are different as males
secrete the hormone in an episodic on-off
rhythm with periods where the hormone cannot be detected. Women produce growth hormone continuously and it is always present in
circulation. Because of these profiles, the levels
of drug metabolizing enzymes are different in

males and females; this may in part explain the
difference in response to drugs, for example
women take longer to emerge from anesthesia

than men. To complicate matters, levels of
growth hormone decline as a person ages.
In earlier studies, Dr. Shapiro’s group had
shown that neonatal administration of normal,
exposure-like levels of both phenobarbital and

Extracorporeal High Energy Shock Wave Therapy
Lithotripsy, the fragmentation of bladderstones by shock waves, is an established treatment in human medicine. Now these shock
waves are utilized in equine medicine to help
heal specific ligament and bone injuries. Dr.
Olga Seco, lecturer in sports medicine and
imaging, and other ultrasound specialists at the
Allam Center for Equine Sports Medicine at
New Bolton Center are compiling data on
horses they are treating with Extracorporeal
High Energy Shock Wave Therapy (ESWT).
The Scott Equine Sports Medicine Building
houses the ESWT equipment. Horses with suspensory ligament desmitis and stress fractures,
and other musculoskeletal problems are treated
with ESWT. In the condition known as suspensory ligament desmitis, the ligament originating in the palmar/plantar aspect of the canon
bone has sustained an injury. This injury can
affect only the ligament, or have an associated
avulsion fracture (piece of bone pulled up at
the area of attachment of the ligament by the
stress caused by the pulling on the ligament). A
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stress fracture is an incomplete fracture that
occurs as the result of repetitive overload and
microfractures in one area of the bone. They
frequently occur in the dorsal aspect of the
canon bone in thoroughbred racehorses.

ESWT is thought to speed healing as well as
relieve pain. Pulsated pressure waves (shock
waves; not electric) are sent to the targeted area

via a probe contained in a head that also incorporates an ultrasound transducer that helps
localize the area of injury during the treatment
and focus very accurately in the area of interest.
Horses with soft tissue injuries usually receive
three treatments at three weeks intervals. For
bony injuries, there is usually one treatment,
but sometimes depending on the response to
the treatment, there can be additional sessions.
Each treatment usually consists on 2,000
shocks delivered to the area of injury. Horses
received this treatment under sedation as the
shock waves cause some pain while being
administered.
Many chronically lame horses become
sounder with ESWT treatment, although no
one knows with any degree of certainty why the
treatment seems to work. It is thought that
increased blood flow may help with the healing
process.
Dr. Seco and Dr. Virginia Reef will present
their findings at the Sports Medicine Symposium in the spring of 2003.

